Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Dopaminergic Modulation of CD4+CD25 Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-β Therapy.
Receptos, Inc. - Current Report: United States Securities and Exchange Commission Form 8-K
Fingolimod phosphate promotes the neuroprotective effects of microglia.
Health Canada Approves PLEGRIDY™ (peginterferon beta-1a) for Adults with Relapsing Remitting Multiple Sclerosis
Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.
First-line natalizumab in multiple sclerosis: rationale, patient selection, benefits and risks.
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study.
Control of experimental autoimmune uveoretinitis by low dose T cell vaccination.
High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases.
Increased PK11195 PET binding in the cortex of patients with MS correlates with disability.
Poor sleep in patients with multiple sclerosis.
Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis.
The Effect of Three Times a Week Glatiramer Acetate on Cerebral T1 Hypointense Lesions in Relapsing-Remitting Multiple Sclerosis.
The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse.
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases.
Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-beta in Lewis rats.
Vitamin D receptor binding, chromatin states and association with multiple sclerosis.
Impact of alemtuzumab treatment on the survival and function of human regulatory T cells in vitro.
Identification of the LDL Receptor-Related Protein-1 Interactome in Central Nervous System myelin suggests a role in the clearance of necrotic cell debris.
Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.
Dalfampridine may activate latent trigeminal neuralgia in patients with multiple sclerosis.
Amiloride HCl
Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis
Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.
Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats.

Pages